Molly Lamb
Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscular Dystrophy, Duchenne | 5 | 2022 | 73 | 1.840 |
Why?
| Diet | 10 | 2019 | 1070 | 1.600 |
Why?
| Autoimmunity | 8 | 2020 | 771 | 1.450 |
Why?
| Islets of Langerhans | 6 | 2014 | 709 | 1.340 |
Why?
| Diabetes Mellitus, Type 1 | 12 | 2020 | 3262 | 1.140 |
Why?
| Body Weight | 2 | 2018 | 1016 | 0.980 |
Why?
| Body Height | 2 | 2016 | 187 | 0.960 |
Why?
| Rural Population | 10 | 2020 | 472 | 0.940 |
Why?
| Child, Preschool | 33 | 2022 | 9655 | 0.720 |
Why?
| Child Nutritional Physiological Phenomena | 3 | 2015 | 100 | 0.680 |
Why?
| Pregnenediones | 1 | 2016 | 19 | 0.640 |
Why?
| Child | 37 | 2022 | 17357 | 0.640 |
Why?
| Dietary Carbohydrates | 2 | 2015 | 160 | 0.630 |
Why?
| Infant | 26 | 2022 | 8024 | 0.630 |
Why?
| Carbohydrates | 1 | 2015 | 64 | 0.600 |
Why?
| HLA-DR Antigens | 2 | 2014 | 236 | 0.590 |
Why?
| Prednisone | 1 | 2016 | 245 | 0.590 |
Why?
| Milk | 2 | 2014 | 141 | 0.580 |
Why?
| Adrenal Cortex Hormones | 1 | 2018 | 489 | 0.570 |
Why?
| Guatemala | 13 | 2021 | 292 | 0.570 |
Why?
| Body Mass Index | 8 | 2020 | 2076 | 0.520 |
Why?
| Disease Progression | 4 | 2015 | 2474 | 0.500 |
Why?
| Infant Food | 2 | 2015 | 68 | 0.490 |
Why?
| Immunoglobulin G | 3 | 2022 | 787 | 0.450 |
Why?
| Influenza, Human | 3 | 2021 | 460 | 0.450 |
Why?
| Eating | 1 | 2014 | 361 | 0.450 |
Why?
| Glucocorticoids | 1 | 2016 | 538 | 0.450 |
Why?
| Audiovisual Aids | 1 | 2010 | 15 | 0.440 |
Why?
| Sexual Maturation | 1 | 2010 | 55 | 0.430 |
Why?
| Hypercholesterolemia | 1 | 2011 | 101 | 0.430 |
Why?
| Hyperlipidemias | 1 | 2011 | 143 | 0.430 |
Why?
| Zika Virus Infection | 3 | 2021 | 82 | 0.410 |
Why?
| Child Development | 3 | 2021 | 469 | 0.410 |
Why?
| Infant, Newborn | 12 | 2021 | 5017 | 0.400 |
Why?
| Overweight | 3 | 2019 | 464 | 0.400 |
Why?
| Male | 40 | 2022 | 60715 | 0.390 |
Why?
| Self Concept | 1 | 2010 | 226 | 0.380 |
Why?
| Humans | 59 | 2022 | 112249 | 0.380 |
Why?
| Delivery, Obstetric | 2 | 2019 | 121 | 0.380 |
Why?
| Glycemic Index | 1 | 2008 | 21 | 0.380 |
Why?
| Meningitis, Bacterial | 2 | 2022 | 52 | 0.380 |
Why?
| Autoantibodies | 5 | 2020 | 1208 | 0.360 |
Why?
| Interviews as Topic | 1 | 2010 | 628 | 0.360 |
Why?
| Caliciviridae Infections | 2 | 2018 | 16 | 0.360 |
Why?
| Norovirus | 2 | 2018 | 22 | 0.360 |
Why?
| Lipids | 2 | 2011 | 619 | 0.350 |
Why?
| Obesity | 5 | 2015 | 2602 | 0.350 |
Why?
| Viral Vaccines | 2 | 2018 | 76 | 0.350 |
Why?
| Female | 41 | 2021 | 62624 | 0.340 |
Why?
| Psychology, Child | 1 | 2007 | 47 | 0.340 |
Why?
| Adolescent | 20 | 2021 | 18577 | 0.340 |
Why?
| Gastroenteritis | 2 | 2017 | 61 | 0.330 |
Why?
| Body Composition | 1 | 2011 | 738 | 0.330 |
Why?
| Adipose Tissue | 1 | 2011 | 662 | 0.330 |
Why?
| Pregnancy | 7 | 2020 | 5185 | 0.310 |
Why?
| Genotype | 4 | 2015 | 2070 | 0.310 |
Why?
| Risk Factors | 13 | 2021 | 8978 | 0.300 |
Why?
| Surveys and Questionnaires | 6 | 2021 | 4549 | 0.280 |
Why?
| Prevalence | 9 | 2021 | 2383 | 0.270 |
Why?
| Cohort Studies | 7 | 2020 | 4937 | 0.270 |
Why?
| Prospective Studies | 10 | 2020 | 6167 | 0.270 |
Why?
| Caregivers | 2 | 2021 | 620 | 0.250 |
Why?
| Young Adult | 13 | 2021 | 10899 | 0.250 |
Why?
| Erythrocyte Membrane | 2 | 2015 | 51 | 0.230 |
Why?
| Oryza | 1 | 2021 | 19 | 0.230 |
Why?
| Cesarean Section | 2 | 2019 | 147 | 0.230 |
Why?
| Meningitis | 1 | 2022 | 64 | 0.230 |
Why?
| Sexually Transmitted Diseases, Viral | 1 | 2021 | 7 | 0.230 |
Why?
| Family Health | 2 | 2015 | 209 | 0.230 |
Why?
| Arsenic | 1 | 2021 | 38 | 0.230 |
Why?
| Lead Poisoning | 1 | 2021 | 24 | 0.220 |
Why?
| Proportional Hazards Models | 3 | 2015 | 1130 | 0.220 |
Why?
| Sarcoma, Kaposi | 1 | 2021 | 66 | 0.220 |
Why?
| Emergency Responders | 1 | 2021 | 35 | 0.220 |
Why?
| Refugees | 1 | 2021 | 41 | 0.220 |
Why?
| Malaria | 1 | 2021 | 58 | 0.220 |
Why?
| Birth Intervals | 1 | 2020 | 21 | 0.220 |
Why?
| Fatty Acids, Omega-3 | 2 | 2015 | 129 | 0.210 |
Why?
| Healthy Lifestyle | 1 | 2020 | 31 | 0.210 |
Why?
| Specimen Handling | 1 | 2022 | 176 | 0.210 |
Why?
| Endpoint Determination | 1 | 2020 | 69 | 0.210 |
Why?
| Molecular Diagnostic Techniques | 1 | 2021 | 95 | 0.210 |
Why?
| Cesarean Section, Repeat | 1 | 2019 | 11 | 0.210 |
Why?
| Breast Feeding | 4 | 2015 | 347 | 0.210 |
Why?
| Parents | 2 | 2010 | 1096 | 0.210 |
Why?
| Vaginal Birth after Cesarean | 1 | 2019 | 22 | 0.210 |
Why?
| Age of Onset | 4 | 2022 | 494 | 0.200 |
Why?
| Adult | 16 | 2021 | 31789 | 0.200 |
Why?
| Language Tests | 1 | 2019 | 37 | 0.200 |
Why?
| Sexual Partners | 1 | 2021 | 149 | 0.200 |
Why?
| Motor Skills | 2 | 2020 | 98 | 0.200 |
Why?
| Dietary Proteins | 2 | 2013 | 124 | 0.200 |
Why?
| Schools | 2 | 2021 | 354 | 0.200 |
Why?
| Language Development Disorders | 1 | 2019 | 49 | 0.200 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 1225 | 0.200 |
Why?
| Follow-Up Studies | 5 | 2021 | 4887 | 0.200 |
Why?
| Multiplex Polymerase Chain Reaction | 1 | 2019 | 38 | 0.200 |
Why?
| Intensive Care Units, Pediatric | 1 | 2021 | 207 | 0.200 |
Why?
| Developing Countries | 1 | 2021 | 242 | 0.190 |
Why?
| Social Class | 2 | 2010 | 220 | 0.190 |
Why?
| Adolescent Health | 1 | 2019 | 34 | 0.190 |
Why?
| Muscular Dystrophies | 1 | 2018 | 36 | 0.190 |
Why?
| Public Health | 2 | 2020 | 419 | 0.190 |
Why?
| Arbovirus Infections | 1 | 2018 | 20 | 0.190 |
Why?
| Public Health Surveillance | 1 | 2018 | 57 | 0.190 |
Why?
| Diarrhea | 1 | 2019 | 173 | 0.190 |
Why?
| Respiratory Tract Infections | 1 | 2021 | 258 | 0.180 |
Why?
| HLA-DR4 Antigen | 2 | 2015 | 72 | 0.180 |
Why?
| HLA-DR3 Antigen | 2 | 2015 | 81 | 0.180 |
Why?
| Sexual Behavior | 2 | 2021 | 444 | 0.180 |
Why?
| HLA-DQ beta-Chains | 2 | 2015 | 73 | 0.180 |
Why?
| Celiac Disease | 1 | 2020 | 212 | 0.180 |
Why?
| Pregnant Women | 1 | 2019 | 101 | 0.180 |
Why?
| Sentinel Surveillance | 1 | 2017 | 39 | 0.180 |
Why?
| Microcephaly | 1 | 2017 | 46 | 0.170 |
Why?
| Antibodies, Viral | 4 | 2022 | 512 | 0.170 |
Why?
| Family Characteristics | 4 | 2021 | 158 | 0.170 |
Why?
| Sex Factors | 5 | 2010 | 1995 | 0.170 |
Why?
| Seroepidemiologic Studies | 3 | 2021 | 129 | 0.170 |
Why?
| Cross-Sectional Studies | 5 | 2018 | 4207 | 0.170 |
Why?
| Cell Phone | 1 | 2017 | 73 | 0.160 |
Why?
| Urban Population | 1 | 2019 | 419 | 0.160 |
Why?
| Health Promotion | 2 | 2020 | 660 | 0.160 |
Why?
| Mental Health Services | 1 | 2021 | 327 | 0.160 |
Why?
| Attitude to Health | 1 | 2020 | 408 | 0.160 |
Why?
| Influenza Vaccines | 1 | 2021 | 407 | 0.160 |
Why?
| Reproducibility of Results | 5 | 2021 | 2877 | 0.160 |
Why?
| Micronutrients | 2 | 2007 | 74 | 0.160 |
Why?
| Age Factors | 6 | 2020 | 3330 | 0.160 |
Why?
| Learning | 1 | 2020 | 368 | 0.160 |
Why?
| Fever | 1 | 2017 | 308 | 0.150 |
Why?
| F2-Isoprostanes | 1 | 2015 | 19 | 0.150 |
Why?
| Neonatal Screening | 1 | 2017 | 179 | 0.150 |
Why?
| Feeding Methods | 1 | 2015 | 9 | 0.150 |
Why?
| Mobile Applications | 1 | 2017 | 124 | 0.150 |
Why?
| Health Resources | 1 | 2017 | 129 | 0.150 |
Why?
| District of Columbia | 2 | 2012 | 18 | 0.140 |
Why?
| Models, Psychological | 1 | 2017 | 341 | 0.140 |
Why?
| Nutrition Policy | 1 | 2015 | 57 | 0.140 |
Why?
| Food Supply | 1 | 2015 | 44 | 0.140 |
Why?
| Walking | 1 | 2018 | 373 | 0.140 |
Why?
| Energy Intake | 2 | 2008 | 493 | 0.140 |
Why?
| Adolescent Behavior | 1 | 2019 | 514 | 0.130 |
Why?
| Population Surveillance | 1 | 2017 | 438 | 0.130 |
Why?
| Sensitivity and Specificity | 4 | 2022 | 1926 | 0.130 |
Why?
| Health Behavior | 1 | 2019 | 716 | 0.130 |
Why?
| Social Support | 1 | 2017 | 539 | 0.130 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 637 | 0.120 |
Why?
| Linear Models | 2 | 2015 | 909 | 0.120 |
Why?
| Contact Tracing | 1 | 2012 | 15 | 0.120 |
Why?
| Case-Control Studies | 2 | 2021 | 3353 | 0.120 |
Why?
| Insulin | 2 | 2015 | 2167 | 0.120 |
Why?
| Transportation | 1 | 2012 | 40 | 0.120 |
Why?
| Psychometrics | 3 | 2021 | 658 | 0.120 |
Why?
| Disease Susceptibility | 1 | 2014 | 356 | 0.120 |
Why?
| HLA Antigens | 2 | 2013 | 240 | 0.110 |
Why?
| Area Under Curve | 2 | 2009 | 328 | 0.110 |
Why?
| Cattle | 1 | 2014 | 976 | 0.110 |
Why?
| Acute Disease | 3 | 2019 | 997 | 0.110 |
Why?
| Tuberculosis, Pulmonary | 1 | 2012 | 115 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 1 | 2016 | 2226 | 0.110 |
Why?
| Nutrition Surveys | 4 | 2015 | 207 | 0.110 |
Why?
| Patient Compliance | 1 | 2015 | 604 | 0.110 |
Why?
| ROC Curve | 2 | 2009 | 486 | 0.100 |
Why?
| United States | 7 | 2020 | 12170 | 0.100 |
Why?
| Fetal Weight | 1 | 2009 | 45 | 0.100 |
Why?
| Chikungunya Fever | 2 | 2021 | 53 | 0.100 |
Why?
| Mycobacterium tuberculosis | 1 | 2012 | 251 | 0.100 |
Why?
| Exercise | 1 | 2020 | 1687 | 0.100 |
Why?
| Pregnancy in Diabetics | 1 | 2009 | 88 | 0.090 |
Why?
| Solanum tuberosum | 1 | 2008 | 7 | 0.090 |
Why?
| Edible Grain | 1 | 2008 | 45 | 0.090 |
Why?
| Feeding Behavior | 1 | 2013 | 562 | 0.090 |
Why?
| Feasibility Studies | 1 | 2010 | 727 | 0.090 |
Why?
| Bias | 1 | 2009 | 182 | 0.090 |
Why?
| Quality Improvement | 3 | 2020 | 915 | 0.090 |
Why?
| Diagnostic Errors | 1 | 2009 | 158 | 0.090 |
Why?
| Stress, Psychological | 1 | 2017 | 1123 | 0.090 |
Why?
| Radiographic Image Enhancement | 1 | 2007 | 68 | 0.080 |
Why?
| Self Disclosure | 1 | 2007 | 66 | 0.080 |
Why?
| Vegetables | 1 | 2008 | 119 | 0.080 |
Why?
| Longitudinal Studies | 4 | 2018 | 2673 | 0.080 |
Why?
| Gestational Age | 1 | 2009 | 765 | 0.080 |
Why?
| Birth Weight | 1 | 2009 | 411 | 0.080 |
Why?
| Mammography | 1 | 2007 | 127 | 0.080 |
Why?
| Quality of Life | 1 | 2017 | 2089 | 0.080 |
Why?
| Weight Gain | 1 | 2009 | 487 | 0.080 |
Why?
| Statistics, Nonparametric | 1 | 2007 | 463 | 0.080 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2013 | 2029 | 0.080 |
Why?
| Mental Recall | 1 | 2007 | 216 | 0.070 |
Why?
| Multivariate Analysis | 1 | 2009 | 1599 | 0.070 |
Why?
| Middle Aged | 7 | 2021 | 28676 | 0.070 |
Why?
| Risk | 2 | 2021 | 944 | 0.070 |
Why?
| Nutritional Status | 1 | 2007 | 280 | 0.070 |
Why?
| Prognosis | 1 | 2013 | 3532 | 0.070 |
Why?
| Genetic Predisposition to Disease | 2 | 2013 | 2406 | 0.070 |
Why?
| Neuropsychological Tests | 2 | 2020 | 1084 | 0.070 |
Why?
| Tobacco Smoke Pollution | 1 | 2007 | 227 | 0.070 |
Why?
| Dietary Fats | 1 | 2007 | 354 | 0.070 |
Why?
| Retrospective Studies | 4 | 2022 | 11118 | 0.070 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2009 | 458 | 0.070 |
Why?
| Databases, Factual | 2 | 2019 | 1184 | 0.070 |
Why?
| Cleft Palate | 2 | 1973 | 49 | 0.060 |
Why?
| Aged, 80 and over | 3 | 2021 | 6778 | 0.060 |
Why?
| Fermentation | 1 | 2021 | 20 | 0.060 |
Why?
| Food Contamination | 1 | 2021 | 23 | 0.060 |
Why?
| Leukocyte Count | 1 | 2022 | 325 | 0.060 |
Why?
| World Health Organization | 1 | 2022 | 111 | 0.060 |
Why?
| Animals | 3 | 2019 | 35194 | 0.060 |
Why?
| Phenotype | 2 | 2022 | 3010 | 0.060 |
Why?
| Mass Screening | 1 | 2009 | 1038 | 0.060 |
Why?
| Seroconversion | 1 | 2021 | 43 | 0.060 |
Why?
| Influenza A Virus, H3N2 Subtype | 1 | 2021 | 29 | 0.060 |
Why?
| School Teachers | 1 | 2021 | 13 | 0.060 |
Why?
| Kenya | 1 | 2021 | 113 | 0.060 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 77 | 0.060 |
Why?
| Brazil | 1 | 2021 | 107 | 0.060 |
Why?
| European Union | 1 | 2020 | 10 | 0.060 |
Why?
| Herpesvirus 8, Human | 1 | 2021 | 75 | 0.050 |
Why?
| India | 1 | 2021 | 152 | 0.050 |
Why?
| Immunoglobulin M | 1 | 2022 | 234 | 0.050 |
Why?
| Diet Surveys | 2 | 2013 | 82 | 0.050 |
Why?
| Chikungunya virus | 1 | 2021 | 51 | 0.050 |
Why?
| Zika Virus | 1 | 2021 | 57 | 0.050 |
Why?
| Absenteeism | 1 | 2020 | 38 | 0.050 |
Why?
| Translations | 1 | 2020 | 15 | 0.050 |
Why?
| Cultural Characteristics | 1 | 2020 | 72 | 0.050 |
Why?
| Cluster Analysis | 1 | 2022 | 491 | 0.050 |
Why?
| Lead | 1 | 2021 | 71 | 0.050 |
Why?
| Colorado | 2 | 2021 | 4552 | 0.050 |
Why?
| Longevity | 1 | 2021 | 176 | 0.050 |
Why?
| Parity | 1 | 2019 | 100 | 0.050 |
Why?
| Respiratory Tract Diseases | 1 | 2021 | 156 | 0.050 |
Why?
| Translating | 1 | 2019 | 32 | 0.050 |
Why?
| Child Language | 1 | 2019 | 30 | 0.050 |
Why?
| Parasites | 1 | 2019 | 30 | 0.050 |
Why?
| Rural Health | 1 | 2019 | 96 | 0.050 |
Why?
| Dengue Vaccines | 1 | 2018 | 9 | 0.050 |
Why?
| Arboviruses | 1 | 2018 | 10 | 0.050 |
Why?
| Culturally Competent Care | 1 | 2019 | 52 | 0.050 |
Why?
| Blood Glucose | 1 | 2008 | 1908 | 0.050 |
Why?
| Coinfection | 1 | 2019 | 109 | 0.050 |
Why?
| Seasons | 1 | 2021 | 439 | 0.050 |
Why?
| Viruses | 1 | 2019 | 89 | 0.050 |
Why?
| Thinness | 1 | 2019 | 90 | 0.050 |
Why?
| Pregnancy in Adolescence | 1 | 2019 | 77 | 0.050 |
Why?
| Forecasting | 1 | 2020 | 399 | 0.040 |
Why?
| Pregnancy Outcome | 1 | 2020 | 340 | 0.040 |
Why?
| Rare Diseases | 1 | 2018 | 96 | 0.040 |
Why?
| Vulnerable Populations | 1 | 2019 | 127 | 0.040 |
Why?
| Anti-Infective Agents | 1 | 2020 | 227 | 0.040 |
Why?
| Chi-Square Distribution | 1 | 2019 | 572 | 0.040 |
Why?
| Child Health | 1 | 2019 | 92 | 0.040 |
Why?
| Gastrointestinal Tract | 1 | 2019 | 162 | 0.040 |
Why?
| Medical Records | 1 | 2018 | 182 | 0.040 |
Why?
| Choice Behavior | 1 | 2019 | 194 | 0.040 |
Why?
| Glucose | 1 | 2022 | 866 | 0.040 |
Why?
| Internal-External Control | 1 | 2017 | 84 | 0.040 |
Why?
| Health Surveys | 1 | 2019 | 497 | 0.040 |
Why?
| Critical Care | 1 | 2021 | 509 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2022 | 2021 | 0.040 |
Why?
| Child Behavior | 1 | 2019 | 259 | 0.040 |
Why?
| Life Change Events | 1 | 2017 | 137 | 0.040 |
Why?
| Breast Neoplasms | 1 | 2007 | 1889 | 0.040 |
Why?
| Risk-Taking | 1 | 2019 | 364 | 0.040 |
Why?
| Cities | 1 | 2015 | 80 | 0.040 |
Why?
| Aged | 3 | 2021 | 20025 | 0.040 |
Why?
| Protective Factors | 1 | 2015 | 92 | 0.040 |
Why?
| Data Collection | 1 | 2018 | 669 | 0.040 |
Why?
| Students | 1 | 2019 | 476 | 0.030 |
Why?
| Intelligence Tests | 1 | 1973 | 78 | 0.030 |
Why?
| Cleft Lip | 1 | 1973 | 37 | 0.030 |
Why?
| Vaccination | 1 | 2021 | 932 | 0.030 |
Why?
| Bacteria | 1 | 2019 | 670 | 0.030 |
Why?
| Hearing Disorders | 1 | 1972 | 22 | 0.030 |
Why?
| Automobiles | 1 | 2012 | 13 | 0.030 |
Why?
| Maryland | 1 | 2012 | 42 | 0.030 |
Why?
| Virginia | 1 | 2012 | 51 | 0.030 |
Why?
| Perceptual Disorders | 1 | 1972 | 32 | 0.030 |
Why?
| Tuberculin Test | 1 | 2012 | 33 | 0.030 |
Why?
| Genetic Markers | 1 | 2013 | 402 | 0.030 |
Why?
| Adaptation, Psychological | 1 | 2017 | 572 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2020 | 2817 | 0.030 |
Why?
| Time Factors | 2 | 2015 | 7054 | 0.030 |
Why?
| Comorbidity | 1 | 2017 | 1597 | 0.030 |
Why?
| Intelligence | 1 | 1972 | 173 | 0.030 |
Why?
| Hospitalization | 1 | 2020 | 1645 | 0.030 |
Why?
| Risk Assessment | 1 | 2021 | 3137 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2013 | 409 | 0.030 |
Why?
| Survival Analysis | 1 | 2015 | 1414 | 0.030 |
Why?
| Hospitals | 1 | 2015 | 452 | 0.030 |
Why?
| Biomarkers | 2 | 2015 | 3464 | 0.030 |
Why?
| Emergency Service, Hospital | 1 | 2020 | 1721 | 0.020 |
Why?
| Clinical Laboratory Techniques | 1 | 2009 | 99 | 0.020 |
Why?
| Environmental Exposure | 1 | 2012 | 423 | 0.020 |
Why?
| Fatty Acids, Omega-6 | 1 | 2007 | 49 | 0.020 |
Why?
| Carotenoids | 1 | 2007 | 32 | 0.020 |
Why?
| Research Personnel | 1 | 2009 | 146 | 0.020 |
Why?
| Vitamins | 1 | 2007 | 141 | 0.020 |
Why?
| Infant Nutritional Physiological Phenomena | 1 | 2007 | 129 | 0.020 |
Why?
| Early Detection of Cancer | 1 | 2009 | 291 | 0.020 |
Why?
| Decision Support Techniques | 1 | 2009 | 386 | 0.020 |
Why?
| Models, Statistical | 1 | 2009 | 688 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2007 | 1002 | 0.010 |
Why?
| Vocabulary | 1 | 1973 | 63 | 0.010 |
Why?
| Language Disorders | 1 | 1972 | 39 | 0.010 |
Why?
| Verbal Learning | 1 | 1972 | 87 | 0.010 |
Why?
| Hearing Tests | 1 | 1972 | 46 | 0.010 |
Why?
|
|
Lamb's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|